Bracket announced its first acquisition since launching last month. Arrowhead Electronic Healthcare, a global provider of electronic Patient-Reported Outcome (ePRO) technologies, will join Bracket. Bracket is committed to building a broad platform of technology tools to improve how pharmaceutical research and development is conducted. Handheld ePRO is a natural complement to Bracket’s existing eClinical platform.
UBC launched Bracket, a Specialty Services provider last month. Adam Butler, vice president at UBC and who is spearheading Bracket, told Applied Clinical Trials: "We formed Bracket on the premise that a comprehensive re-examination of how pharmaceutical research and development is conducted was required. I think it's clear that the combination of technology tools and clinical expertise will be a core part of how we improve R&D, and I expect to see an increasing focus on improving the way we integrate technology into these programs." For more on the Bracket launch, listen to this podcast.
As part of the Arrowhead acquisition,
· Arrowhead’s ePRO solutions will be integrated into Bracket’s existing suite of eClinical tools, including IVRS, IWRS, and e-Learning platforms.
· Arrowhead's ePRO solutions are uniquely engineered to better capture the true patient experience in clinical studies so trial sponsors can focus on making better, faster drug development decisions.
· Independent research indicates sharp increases in the adoption and use of handheld ePRO tools in clinical trials over the next two years.
· Arrowhead's ePRO-LOG™ software platform is used on smartphones, tablet computers, the Web, and text messaging applications.
Arrowhead’s trademarked technologies include:
· ePRO-LOG™ Smartphone
· Ideal for frequently administering questionnaires and when portability and alarm reminders are essential.
· ePRO-LOG™ Tablet
· Excellent for studies where content is dense, moderate portability is needed, and Internet availability is limited. ePRO-LOG™ Tablet can be deployed at site or patients' homes; many Quality of Life questionnaires are good candidates for tablet computers.
· ePRO-LOG™ Web
· ePRO-LOG™ Web works well on studies with dense content and where patients have regular access to Web sites or 3G Web-enabled phones. ePRO-LOG™ Web can be administered at home or in clinic; many Quality of Life questionnaires are good candidates for Web.
· ePRO-LOG™ SMS
· Optimal for simple data logging and alert notifications, ePRO-LOG™ SMS is highly mobile and relatively inexpensive.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.